1 / 14

A Guide to ShireSupport Updated: Spring 2012

A Guide to www.ShireSupport.com Updated: Spring 2012. Shire Pharmaceuticals-SP. www.ShireSupport.com. The following slides provide an orientation on Shire Pharmaceuticals-SP Registration eligibility and submission Therapeutic areas Funding types Definitions of funding types

ahanu
Télécharger la présentation

A Guide to ShireSupport Updated: Spring 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Guide towww.ShireSupport.comUpdated: Spring 2012 Shire Pharmaceuticals-SP

  2. www.ShireSupport.com • The following slides provide an orientation on • Shire Pharmaceuticals-SP • Registration eligibility and submission • Therapeutic areas • Funding types • Definitions of funding types • Funding availability • Contact information

  3. Registration and Submission Process • Step One • Become a registered user of www.ShireSupport.com • When registering please have the following materials available • Legal name of the organization as registered with the IRS • A signed PDF copy of the organization’s W9 form • Note: Electronic signatures are NOT acceptable • If applicable, a PDF copy of the organization’s non-profit determination letter from the IRS • Step Two • Select the request type • Medical education grants • Healthcare related Charitable Contributions and/or Sponsorship requests • Step Three • Submit the request with attachments as applicable

  4. Eligible Medical Schools Hospitals/Medical Centers Medical Associations/Medical Societies Patient Advocacy Organizations Medical Education Companies Not for Profit organizations 501(c)(3)(4)(6) Ineligible Individuals Private or group medical practice(s) An organization that has been debarred or is on the OIG exclusion list Registration Eligibility Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is unable to fund requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care practitioners attending any CME event, third-party scientific or educational conference, or professional meetings, either directly to the individuals participating in the event or indirectly to the event’s sponsor.  While Shire has information on the charitable section of this website relating to Fellows and Residents travel grants, any organizations located in Massachusetts are not eligible due to this law.

  5. Therapeutic Areas of Interest • ADHD • Adult • ADHD is a chronic neurologically based disease. Therefore Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of adult patients with ADHD. • Adolescents • ADHD is a chronic neurologically based disease. Therefore Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of adolescent patients with ADHD. • Pediatric • ADHD is a chronic neurologically based disease. Therefore Shire’s educational goal is to improve the screening, diagnosis, treatment, and management of pediatric patients with ADHD.

  6. Therapeutic Areas of Interest • Gastroenterology • Mild to Moderate Ulcerative Colitis • Mild to moderate ulcerative colitis is a disease characterized by inflammation and ulceration of the lining of the colon and rectum. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of patients with mild to moderate ulcerative colitis. • Motility/Chronic Constipation • Chronic constipation is characterized by infrequent and difficult passage of stools over a prolonged period and a range of bothersome symptoms. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of female patients with chronic constipation. • Renal • Hyperphosphatemia • Hyperphosphatemia is an abnormal concentration of phosphates in the blood. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of patients with hyperphosphatemia.

  7. Definitions of Funding Types

  8. Definitions of Funding Types Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is unable to fund requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care practitioners attending any CME event, third-party scientific or educational conference, or professional meetings, either directly to the individuals participating in the event or indirectly to the event’s sponsor.  While Shire has information on the charitable section of this website relating to Fellows and Residents travel grants, any organizations located in Massachusetts are not eligible due to this law.

  9. Definitions of Funding Types

  10. Shire Pharmaceuticals-SP – 2012 Funding Availability

  11. Financial Reconciliation of Educational Grants • Educational grants must be reconciled within 90 days of the activity date • Reconciliations are to be completed online at www.ShireSupport.com • What’s needed • Complete the online reconciliation form with • Attendance information • Comparative budget to actual reconciliation (Program expenses for the entire initiative; not just what Shire provided) • Total Funding received from all sources = registration income, educational grants, and funding provided by the hosting organization • The evaluation summary • Documentation of the commercial support acknowledgement statement, i.e. “This activity was supported by an independent medical educational grant from Shire.” • Refunds are only due if the amount is greater than $250 • Failure to reconcile educational grants may prevent future funding to your organization.

  12. Financial Reconciliation of Sponsorships • All sponsorships must be reconciled within 90 days of the activity date • Reconciliations are to be completed online at www.ShireSupport.com • What’s needed • Comparative budget to actual reconciliation • Program expenses for the entire initiative must be included (not just funding provided by Shire) • Documentation of the commercial support acknowledgement statement • Note that failure to reconcile this request may prevent future Charitable and/or Sponsorship funding to your organization.

  13. Some Reminders… • Funding requests must be aligned to a Shire Pharmaceuticals-SP therapeutic area of interest to be considered • Funding requests must be submitted online to www.ShireSupport.com by the requesting organization without assistance from Shire employees • Faxed, mailed, or e-mailed requests will not be reviewed • Funding requests must be in compliance with all applicable guidelines • Timelines • All requests – educational, charitable contributions, or sponsorships – must be submitted 60 days in advance • Decisions are communicated by e-mail within 30-60 days of the request date • Requests will not be reviewed or approved after the activity has begun or taken place • Submission, or past approvals, does not guarantee support • Declined requests cannot be resubmitted • Educational grant requests should not include sponsorship requests and vice versa • Questions? • Shire Pharmaceuticals-SP: ShireSupport@shire.com

  14. Contact Information

More Related